证券之星消息，惠泰医疗近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利 8.206亿元，同比增长21.91%。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 该股最近90天内共有5家机构给出评级，买入评级4家，增持评级1家。 惠泰医疗（688617）主营业务：公司是一家专注于电生理和血管介入医疗器械的研发、生产和销售的高 新技术企业,已形成了以完整冠脉通路和电生理医疗器械为主导,外周血管和神经介入医疗器械为重点发 展方向的业务布局。 ...

Core Viewpoint - The financial performance of Huitai Medical (688617) shows significant growth in revenue and net profit, indicating a strong position in the medical device industry focused on electrophysiology and vascular intervention [3]. Financial Performance - For the first three quarters of 2025, Huitai Medical reported a main revenue of 1.867 billion yuan, a year-on-year increase of 22.47% [3]. - The net profit attributable to shareholders reached 623 million yuan, up 18.02% year-on-year [3]. - The third quarter alone saw a main revenue of 654 million yuan, reflecting a 24.77% increase compared to the same quarter last year [3]. - The net profit for the third quarter was 198 million yuan, with a year-on-year growth of 6.77% [3]. - The company maintained a gross profit margin of 73.19% [3]. Financing and Trading Activity - On February 9, 2026, Huitai Medical's stock closed at 229.38 yuan, with a trading volume of 7315 hands and a total transaction amount of 167 million yuan [1]. - The net inflow of main funds was 12.89 million yuan, accounting for 7.71% of the total transaction amount, while retail investors saw a net outflow of 1.67 million yuan [1]. - The financing data indicated a net financing purchase of 3.12 million yuan on the same day, with a total financing balance of 181 million yuan [2]. Institutional Ratings - In the last 90 days, four institutions provided ratings for Huitai Medical, with three giving a "buy" rating and one an "increase" rating [4].

Core Viewpoint - Huatai Medical (688617) experienced a decline of 2.15% in stock price, closing at 279.0 yuan on November 13, 2025, with a trading volume of 6,989 hands and a turnover of 196 million yuan [1]. Fund Flow Summary - On November 13, 2025, the net outflow of main funds was 1.27 million yuan, accounting for 0.65% of the total turnover, while retail funds saw a net inflow of 2.80 million yuan, representing 1.43% of the total turnover [1][2]. - Over the past five days, the stock has shown fluctuating fund flows, with significant net outflows from main funds on several days, particularly on November 10, where the outflow reached 15.36 million yuan [2]. Financing and Margin Trading Data - On November 13, 2025, the financing balance was 151 million yuan, with a net financing purchase of 5.35 million yuan. The margin trading balance stood at 168 million yuan [3]. - The stock's margin trading data indicates a consistent level of activity, with a total of 6,100 shares remaining in the margin account as of November 13, 2025 [3]. Company Performance Metrics - Huatai Medical's market capitalization is 39.34 billion yuan, ranking 4th in the medical device industry, while its net profit of 623 million yuan places it 9th in the same sector [4]. - The company reported a year-on-year revenue increase of 22.47% for the first three quarters of 2025, with a net profit growth of 18.02% [4]. - The gross profit margin stands at 73.19%, significantly higher than the industry average of 51.22%, indicating strong operational efficiency [4]. Institutional Ratings - In the last 90 days, 14 institutions have rated Huatai Medical, with 12 buy ratings and 2 hold ratings, suggesting a positive outlook among analysts [5]. - The average target price set by institutions over the past 90 days is 363.54 yuan, indicating potential upside from the current trading price [5].

证券之星消息，截至2025年9月3日收盘，惠泰医疗(688617)报收于315.42元，上涨3.12%，换手率1.69%，成交量2.38万手，成交额7.5亿元。 9月3日的资金流向数据方面，主力资金净流入1.07亿元，占总成交额14.34%，游资资金净流出1.04亿元，占总成交额13.89%，散户资金净流出 333.64万元，占总成交额0.45%。 近5日资金流向一览见下表： | 日期 | | 涨跌幅 融资余额(元) | 融资净买入(元) | 融券余量(股) | 融券净卖出(股) | 融资融券余额(元) | | --- | --- | --- | --- | --- | --- | --- | | 2025-09-03 | 3.12% | 8427.71万 | 238.14万 | 3.60万 | 3366.0 | 9563.34万 | | 2025-09-02 | 0.12% | 8189.56万 | -1224.49万 | 3.26万 | 9717.0 | 9187.86万 | | 2025-09-01 | 7.43% | 9414.06万 | -1768.94万 | 2.29万 | -3768.0 | 1 ...